HPLC
IndustriesOther
ManufacturerWaters
Significance of the Topic
Analytical methods based on HPLC are critical for quality control and regulatory compliance in pharmaceutical and food industries. The ability to transfer methods across different systems and meet stringent monograph criteria ensures reproducible results, streamlined workflows, and rapid response to evolving analytical challenges.
Study Objectives and Overview
The series of application cases aimed to demonstrate the performance and versatility of the Waters Alliance iS HPLC System in:
- Analysis of soft drink additives and their degradation products.
- Replication and migration of HILIC methods for water-soluble vitamins.
- Troubleshooting peak splitting for cetirizine assays.
- System robustness under high-salt gradient conditions for azithromycin impurities.
- Monograph compliance for atorvastatin, aspirin, quetiapine, ibuprofen, naphazoline/pheniramine, and abacavir sulfate.
- Reduction of carryover for chlorhexidine analyses.
Methodology and Instrumentation
All studies employed isocratic and gradient HPLC techniques, including reversed-phase and HILIC modes. Key system features included high-pressure capability for modern columns, precise low-volume injections, robust wash protocols, and extended pressure limits. Instrumentation details are listed below.
Instrumentation Used
- Waters Alliance iS HPLC System.
- Waters XSelect HSS T3, CSH C18, and other UPLC columns.
- ACQUITY APC Reservoir Caps and temperature-controlled autosampler.
Key Results and Discussion
- Soft drinks study achieved complete separation of six additives and aspartame degradants in 17 min with RSD <0.001 and resolution of 2.3.
- HILIC method migration for vitamins and cetirizine met USP suitability, with improved signal-to-noise and reliable peak shapes after optimized needle wash.
- Azithromycin assay displayed stable retention times over 30 h under high-salt gradients, outperforming legacy systems.
- Atorvastatin and aspirin monographs yielded RSD <0.6% for peak area and retention time, with temperature and septa controls minimizing evaporation.
- Quetiapine and ibuprofen impurity methods were successfully migrated across three systems, showing quantitative agreement within 0.01%.
- Combined naphazoline-pheniramine ophthalmic/nasal solution assay separated all APIs and impurities in one 20 min run.
- Abacavir modernization using USP <621> gradient allowances reduced runtime and solvent use with modern column dimensions.
- Chlorhexidine carryover was mitigated by enhanced wash cycles and tool-free fittings, eliminating volumetric and adsorptive residue.
Benefits and Practical Applications
- Streamlined method transfer and reduced validation workload.
- Improved precision and robustness across diverse monographs.
- Higher throughput with shorter runtimes and solvent savings.
- Enhanced system longevity under challenging mobile phase conditions.
- Reduced analyst error with intuitive instrument features.
Future Trends and Opportunities
The integration of smart diagnostics, AI-driven method optimization, and fully automated workflows will further simplify method migration. Expanded gradient allowances and high-throughput configurations will enable real-time monitoring and adaptive sampling in regulated labs.
Conclusion
The Waters Alliance iS HPLC System offers a unified platform for diverse QC applications, meeting stringent USP requirements while improving precision, robustness, and throughput. Its intuitive design and high-pressure capabilities support modern chromatographic strategies and streamline laboratory operations.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.